Aurum Ventures provides venture capital with a focus on Israeli life science companies. Aurum Ventures is stage agnostic, but has a strong focus on therapeutics within fields of significant medical and health problems. Aurum Ventures is presently invested in major therapeutics areas such as cancer, inflammation, heart failure, diabetes, GI, surgical, HIV and others.